Follow The Filings

LAB position history

The shares of Standard Biotools (LAB) that Corvex Management LP reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 44,400 shares, $120K, <0.01% of portfolio, New
  2. 2024 Q2: 44,400 shares, $79K, <0.01% of portfolio
  3. 2024 Q3: 44,400 shares, $86K, <0.01% of portfolio
  4. 2024 Q4: 44,400 shares, $78K, <0.01% of portfolio
  5. 2025 Q1: 44,400 shares, $48K, <0.01% of portfolio
  6. 2025 Q2: 44,400 shares, $53K, <0.01% of portfolio
  7. 2025 Q3: 44,400 shares, $58K, <0.01% of portfolio
  8. 2025 Q4: 44,400 shares, $57K, <0.01% of portfolio
  9. 2026 Q1: 44,340 shares, $41K, <0.01% of portfolio, Reduce −0.1%
  10. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders